Back to top
more

Equinix (EQIX)

(Delayed Data from NSDQ)

$921.06 USD

921.06
535,955

+13.32 (1.47%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $921.42 +0.36 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 250)

Industry: REIT and Equity Trust - Retail

Zacks News

SL Green's (SLG) FFO and Revenues Surpass Estimates in Q1

SL Green's (SLG) Q1 earnings outshine estimates on better-than-anticipated revenues. However, the occupancy in the company's Manhattan same-store office portfolio falls year over year.

Is a Beat in Store for Boston Properties (BXP) in Q1 Earnings?

Despite declining office-space demand, Boston Properties' (BXP) Q1 earnings are likely to have benefited from the healthy demand for its flight-to-quality office properties and life-science assets.

Nalak Das headshot

5 REIT Stocks to Buy Ahead of Q1 2023 Earnings Results

We have narrowed our search to five U.S. REITs that are set to report first-quarter 2023 earnings results. These are: AGNC, REXR, VICI, EGP and EQIX.

Equinix (EQIX) to Expand Into Montreal With New Data Center

As part of its expansion efforts into Canada, Equinix (EQIX) announces a new data center facility in Montreal with an investment of $50 million.

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Equinix (EQIX) have what it takes? Let's find out.

Here's Why Equinix's (EQIX) Shares Soared 11.4% in 6 Months

Robust data-center demand, healthy operating performance, strategic expansions and solid balance-sheet strength drive Equinix's (EQIX) 11.4% rise in the past six months.

The Zacks Analyst Blog Highlights Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix

Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Johnson & Johnson, Toyota Motor & Infosys

Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Toyota Motor Corporation (TM) and Infosys Limited (INFY).

Equinix's (EQIX) Tokyo IBX Data Center to Get Quantum Computers

Equinix (EQIX) announces that Oxford Quantum Circuits aims to make one of the most powerful quantum computers through Equinix's TY11 Tokyo IBX data center, easing access to quantum computing to aid businesses.

Equinix (EQIX) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Equinix (EQIX) have what it takes? Let's find out.

SKT vs. EQIX: Which Stock Is the Better Value Option?

SKT vs. EQIX: Which Stock Is the Better Value Option?

Equinix (EQIX) Ups Renewable Power Game With Spain Solar Farms

As part of its efforts to boost renewable power generation globally, Equinix (EQIX) adds five new long-term Power Purchase Agreements in Spain, totaling 225 megawatts.

Equinix's (EQIX) Q4 AFFO & Revenues Top, Dividend Hiked

Equinix (EQIX) posts stellar Q4 results backed by strong demand for its colocation and interconnection services. It raises dividend payment on solid operating performance and issues an upbeat view.

Equinix (EQIX) Beats Q4 FFO and Revenue Estimates

Equinix (EQIX) delivered FFO and revenue surprises of 3.96% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Agree Realty (ADC) Q4 FFO Match Estimates

Agree Realty (ADC) delivered FFO and revenue surprises of 0% and 0.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for Equinix (EQIX) This Earnings Season?

Equinix's (EQIX) Q4 earnings are likely to have benefited from the robust demand for data centers and strategic expansion moves. However, a stronger U.S. dollar might have been a deterrent.

Phillips Edison & Company, Inc. (PECO) Tops Q4 FFO and Revenue Estimates

Phillips Edison & Company, Inc. (PECO) delivered FFO and revenue surprises of 3.70% and 0.40%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SITE CENTERS CORP. (SITC) Tops Q4 FFO and Revenue Estimates

SITE CENTERS CORP. (SITC) delivered FFO and revenue surprises of 3.57% and 0.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Boston Properties (BXP) to Post Q4 Earnings: What's in Store?

Despite declining office-space demand, Boston Properties' (BXP) Q4 earnings are likely to have benefited from the healthy demand for its flight-to-quality office properties and life-science assets.

Crown Castle (CCI) Q4 FFO & Revenues Beat on Solid Demand

Crown Castle's (CCI) Q4 earnings outshine estimates on elevated tower space demand for 5G deployment. Site-rental revenues grow year over year, aiding the top line.

SL Green's (SLG) Q4 FFO and Revenues Fall Shy of Estimates

SL Green's (SLG) Q4 earnings miss estimates on lower-than-anticipated revenues and a fall in occupancy. However, same-store cash net operating income improves year over year.

Zacks Investment Ideas feature highlights: Equinix

Equinix are part of the Zacks Investment Ideas article.

Bryan Hayes headshot

REITs Back in Favor as Rate Path Becomes Clear

Last year's performance has created a phenomenal opportunity to buy these undervalued, oft-forgotten investment vehicles.

What's in Store for Crown Castle (CCI) This Earnings Season?

Crown Castle's (CCI) Q4 earnings are likely to have benefited from the rise in demand for tower leasing by wireless network carriers for 5G deployment and network expansion.

Sheraz Mian headshot

Top Stock Reports for Thermo Fisher Scientific, Starbucks & Moderna

Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Starbucks Corporation (SBUX) and Moderna, Inc. (MRNA).